# Atrial Sensing Capability for Better Detection of Atrial Fibrillation

> **NCT03932604** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 640 (estimated)

## Conditions studied

- Implantable Cardioverter Defibrillator
- Atrial Fibrillation
- Cardiac Event
- Cardiac Arrhythmia

## Interventions

- **DEVICE:** Atrial sensing On mode

## Key facts

- **NCT ID:** NCT03932604
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 640 (ESTIMATED)
- **Last updated:** 2021-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932604, "Atrial Sensing Capability for Better Detection of Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03932604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*